Onyx Pharmaceuticals Inc., of South San Francisco, named Pablo J. Cagnoni executive vice president, global research and development and technical operations

MyoKardia Inc., of South San Francisco, named Jonathan C. Fox chief medical officer...Protea Biosciences Inc., of Morgantown, W. Va., added Thijs Spoor and Josiah T. Austin to its board

Oxigene Inc., of South San Francisco, added David (Dai) Chaplin to its board...Rexahn Pharmaceuticals Inc., of Rockville, Md., named Peter D. Suzdak CEO and Chang AHN chief scientist

GeNO LLC, of Waltham, Mass., named Kurt Dasse president and Barry Gellman senior vice president, engineering...Onyx Pharmaceuticals Inc., of South San Francisco, named N. Anthony Coles chairman of its board

Five Prime Therapeutics Inc., of South San Francisco, appointed Julie Hambleton senior vice president and chief medical officer

Sunesis Pharmaceuticals Inc., of South San Francisco, appointed Deborah A. Thomas vice president, regulatory affairs, and Gene C. Jamieson vice president, chemistry, manufacturing and controls

Tobira Therapeutics Inc., of South San Francisco, named Caroline Loewy executive vice president and chief financial officer, Jeff Enejosa senior director, clinical research and Mark Menning director, pharmaceutical sciences

Eli Lilly and Co., of Indianapolis, named Michael Harrington senior vice president and general counsel...Hyperion Therapeutics Inc., of South San Francisco, added Daniel G. Welch to its board

Mark Oki senior vice president, finance and chief financial officer...Portola Pharmaceuticals Inc., of South San Francisco, added Robert Califf to its board

KaloBios Pharmaceuticals Inc., of South San Francisco, named Jeffrey Cooper chief financial officer...Onyx Pharmaceuticals Inc., of South San Francisco, named John Osborn senior vice president, global corporate affairs

KaloBios Pharmaceuticals Inc., of South San Francisco, appointed Nestor Molfino chief medical officer...Macrocure, of Petach Tikva, Israel, named Nissim Mashiach president and CEO

Ipierian Inc., of South San Francisco, appointed Pamela Conley vice president of research...Paratek Pharmaceuticals Inc., of Boston, appointed Dennis Molnar CEO and director and Evan Loh chief medical officer and board chairman

Five Prime therapeutics Inc., of South San Francisco, named Aron Knickerbocker senior vice president and chief business officer

Threshold Pharmaceuticals Inc., of South San Francisco, appointed Robert Simon senior vice president of regulatory affairs...XOMA Corp., of Berkeley, Calif., named Paul Rubin senior vice president, research and development

Veracyte Inc., of South San Francisco, named Richard Kloos senior medical director...named CFO Timothy Morris senior vice president, global corporate development and finance

and Christine Mikail, executive vice president, corporate development, general counsel and secretary...Onyx Pharmaceuticals Inc., of South San Francisco, named Luigi Costa vice president and head of Europe

Sunesis Pharmaceuticals Inc., of South San Francisco, appointed Adam R. Craig executive vice president of development and chief medical officer, as of March 1...Tobira Therapeutics Inc., of South San Francisco, appointed Eric Lefebvre chief medical officer and named Martine Kraus vice president of regulatory affairs...Veracyte Inc., of South San Francisco, appointed Mark Spring chief financial officer

Five Prime Therapeutics Inc., of South San Francisco, appointed Lewis T...Rusty" Williams president and CEO and named Brian Atwood chairman

and Jim Rouse as vice president and chief information officer...Threshold Pharmaceuticals Inc., of South San Francisco, appointed Nipun Davar vice president of pharmaceutical development and manufacturing